Kardigan, a biopharmaceutical company focused on innovative cardiovascular treatments, is strategically pursuing an Initial Public Offering (IPO) on the Nasdaq…
Read More

Kardigan, a biopharmaceutical company focused on innovative cardiovascular treatments, is strategically pursuing an Initial Public Offering (IPO) on the Nasdaq…
Read More